Pharmaceutical and healthcare market research services across EMEA
From statistically powered physician surveys to payer and HTA strategy, BioNixus runs the full arc of pharmaceutical and healthcare market research across 17+ countries in Europe, the Middle East, and North Africa — every engagement scoped to a real commercial decision, not a template.
Modular research for pharmaceutical teams
Every service below opens a dedicated page with scope notes, typical deliverables, and country-level nuance. Our quantitative work is built on representative sampling, transparent quotas, and statistical reporting your leadership team can defend in a governance review — not headline percentages with no visible base sizes.
Our qualitative work is built on discussion guides that surface real clinical behaviour rather than rehearsed slogans, and synthesis that turns transcripts into decisions. Market access, competitive intelligence, and KOL modules slot into the same program and sequence to your launch calendar.
Quantitative Healthcare Research & Physician Surveys
Statistically powered surveys with physicians and healthcare professionals across 17+ EMEA markets. Online and telephone fieldwork at defined sample sizes (n=50 to 500+), reported with the base sizes, quotas, and significance testing decision-makers expect.
Learn moreQualitative Pharmaceutical Research & Expert Insights
In-depth interviews, focus groups, and advisory boards with KOLs, treating physicians, payers, and hospital decision-makers across the UK, Europe, and MENA — designed to explain the why behind adoption and access, not just the what.
Learn moreMarket Access & HTA Strategy
Evidence-led pricing, payer engagement, and value-story testing for UK, EU5, and GCC markets, with HTA submission support mapped to NICE, G-BA, HAS, and Gulf health authority expectations.
Learn moreCompetitive Intelligence
Competitor monitoring, pipeline and landscape assessments, launch-readiness reviews, and biosimilar impact studies — turned into a clear read on where your brand can realistically win.
Learn moreClinical Trial Support
Site identification, investigator profiling, patient-recruitment feasibility, protocol feedback from treating physicians, and post-launch real-world evidence to support trials across the region.
Learn moreKOL & Stakeholder Mapping
Identification and engagement of the key opinion leaders, committees, and procurement voices that actually shape decisions — with ethnographic research, patient-journey mapping, and treatment-pathway analysis across the UK, Europe, and MENA.
Learn moreRelated research hubs
Explore regional hubs and guides most often used alongside these service modules.
- Healthcare market research hub
- Market research services overview
- Saudi Arabia pharmaceutical research
- UAE healthcare market research
- Global websites directory
- Healthcare case studies
More research guides48 links
- Middle East Pharmaceutical Market Research
- Healthcare Market Research in Europe (2026 Guide)
- Healthcare Market Research Methodologies for the GCC
- Healthcare Market Research in the UAE — 2025 Guide
- Hospital Market Research for Pharma
- Pharmaceutical Market Access Research in the UAE
- Pharmaceutical Market Research in the GCC
- Pharmaceutical Market Research in the UK (2026 Guide)
- Quantitative Market Research and Market Access
- Top Healthcare Market Research Companies in MENA
- Healthcare Market Research in Algeria
- Healthcare Market Research in Bahrain
- Canada
- China
- Denmark
- Egypt
- France
- Germany
- Iraq
- Italy
- Japan
- Jordan
- Kenya
- Kuwait
- Lebanon
- Libya
- Morocco
- Nigeria
- Oman
- Qatar
- Saudi Arabia
- Singapore
- South Africa
- Spain
- Sweden
- Switzerland
- Tunisia
- Turkey
- United Arab Emirates
- United States
- Qualitative Market Research
- Quantitative Healthcare Market Research
- Clinical Trial Support
- Competitive Intelligence
- Quantitative Market Research And Market Access
- Saudi Healthcare Market Research Firms Ar
- Mexico
- Uk
Frequently asked questions
Which BioNixus service fits a pre-launch pharmaceutical program?
Most launch teams combine quantitative physician surveys with qualitative KOL depth and market access support. We scope modules to your phase—feasibility, positioning, pricing, or HTA—and sequence fieldwork to match your governance calendar.
Can we commission one service or an integrated program?
Both. Each card below links to a dedicated scope page. You can run a standalone quantitative wave, a qualitative advisory board, or a multi-market program where modules share sampling logic and reporting templates.
Which geographies do these services cover?
BioNixus executes across 17+ EMEA and MENA markets, including the UK, EU5, GCC, Egypt, and North Africa, with bilingual Arabic–English field teams where required.
How quickly can we receive a proposal?
Share your objective, audience, and timeline via the contact form. We typically return a tailored methodology outline within one business day.
Talk with BioNixus research specialists
Our team supports pharmaceutical companies with decision-ready insights across MENA, UK, and Europe using quantitative and qualitative methodologies.
US No. +1 888 465 5557Europe No. +44 7727 666682Middle East, Africa and Asia No. +20 120 688 2323